Literature DB >> 26201786

Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia.

Seok-Chin Goh1, Evelyn Lai-Ming Ho2, Khean-Lee Goh3.   

Abstract

BACKGROUND: The prevalence of non-alcoholic fatty liver disease (NAFLD) in the Malaysian population is not known. Malaysia has a multiracial Asian population with three major Asian races: Malay, Chinese, and Indian living together. The aim of the study is to determine the prevalence and risk factors in a suburban Malaysian population.
METHODS: Consecutive subjects who came for a health checkup at a suburban medical facility were recruited for the study. All individuals had clinical assessments, anthropometric measurements, blood tests, and ultrasonography of the liver performed. Those with significant alcohol consumption and history of chronic liver disease were excluded.
RESULTS: Of the 1,621 "health screened" individuals analyzed, 368 (22.7 %) were found to have NAFLD. They comprised Chinese 1,269 (78.3 %), Malay 197 (12.1 %), and Indian 155 (9.6 %). Males and "older" age group ≥45 years had high prevalence rates with the highest in Indian (68.2 %) and Malay (64.7 %) males. Chinese females <45 years had the lowest prevalence of 5.2 %. A significant increase in the prevalence of fatty liver between age <45 years and ≥45 years was seen in female of all three races but in male, this increase was seen only among the Indians. NAFLD was strongly associated with diabetes mellitus, glucose intolerance, body mass index ≥23, low high-density lipoprotein cholesterol, hypertriglyceridemia, and hypertension.
CONCLUSION: NAFLD is common in suburban Malaysian population. Older Indian and Malay males have an inordinately high prevalence of the disease.

Entities:  

Keywords:  Chinese; Indian; Malay; Multiracial Asian population; Non-alcoholic fatty liver disease

Year:  2012        PMID: 26201786     DOI: 10.1007/s12072-012-9359-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  35 in total

1.  Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality.

Authors:  K Hughes; K C Lun; P P Yeo
Journal:  J Epidemiol Community Health       Date:  1990-03       Impact factor: 3.710

2.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

3.  Prevalence of diabetes, hypertension and renal disease amongst railway workers in Malaysia.

Authors:  B A Khalid; R Usha; M L Ng; C T Norella Kong; A R Tariq
Journal:  Med J Malaysia       Date:  1990-03

4.  Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults.

Authors:  Seung H Park; Woo K Jeon; Sang H Kim; Hong J Kim; Dong I Park; Yong K Cho; In K Sung; Chong I Sohn; Dong K Keum; Byung I Kim
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

5.  Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: a nationwide population study in Malaysia.

Authors:  Sanjay Rampal; Lekhraj Rampal; Ramlee Rahmat; Azhar Md Zain; Yee Guan Yap; Mafauzy Mohamed; Mohamad Taha
Journal:  Asia Pac J Public Health       Date:  2009-05-14       Impact factor: 1.399

Review 6.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

7.  A national study on the prevalence of obesity among 16,127 Malaysians.

Authors:  Lekhraj Rampal; Sanjay Rampal; Geok Lin Khor; Azhar Md Zain; Shafie Bin Ooyub; Ramlee Bin Rahmat; Sirajoon Noor Ghani; Jayanthi Krishnan
Journal:  Asia Pac J Clin Nutr       Date:  2007       Impact factor: 1.662

8.  Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.

Authors:  Anuradha S Dassanayake; Anuradhani Kasturiratne; Shaman Rajindrajith; Udaya Kalubowila; Sureka Chakrawarthi; Arjuna P De Silva; Miyuki Makaya; Tetsuya Mizoue; Norihiro Kato; A Rajitha Wickremasinghe; H Janaka de Silva
Journal:  J Gastroenterol Hepatol       Date:  2009-05-19       Impact factor: 4.029

Review 9.  Cardiovascular mortality in Peninsular Malaysia: 1950-1989.

Authors:  K L Khoo; H Tan; T H Khoo
Journal:  Med J Malaysia       Date:  1991-03

10.  Convergence of obesity and high glycemic diet on compounding diabetes and cardiovascular risks in modernizing China: an emerging public health dilemma.

Authors:  Eric L Ding; Vasanti S Malik
Journal:  Global Health       Date:  2008-02-26       Impact factor: 4.185

View more
  26 in total

1.  Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.

Authors:  Wah-Kheong Chan; Nik Raihan Nik Mustapha; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Sanjiv Mahadeva
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

Review 2.  Nonalcoholic fatty liver disease in Asia: emerging perspectives.

Authors:  Wai-Kay Seto; Man-Fung Yuen
Journal:  J Gastroenterol       Date:  2016-09-16       Impact factor: 7.527

3.  Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males.

Authors:  Wah-Kheong Chan; Norhaniza Bahar; Hamizah Razlan; Anushya Vijayananthan; Pavai Sithaneshwar; Khean-Lee Goh
Journal:  Hepatol Int       Date:  2014-01-03       Impact factor: 6.047

4.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

Review 5.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

6.  Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population.

Authors:  Kevin Beng Chin Khaw; Rachel Huiyi Choi; Juinn Huar Kam; Bibhas Chakraborty; Pierce Kah Hoe Chow
Journal:  Singapore Med J       Date:  2016-12-20       Impact factor: 1.858

7.  Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.

Authors:  Chan Wah-Kheong; Goh Khean-Lee
Journal:  Hepatol Int       Date:  2012-06-15       Impact factor: 6.047

8.  Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease.

Authors:  Sivesh K Kamarajah; Wah-Kheong Chan; Nik Raihan Nik Mustapha; Sanjiv Mahadeva
Journal:  Hepatol Int       Date:  2018-01-25       Impact factor: 6.047

Review 9.  Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review.

Authors:  Reza Karbasi-Afshar; Amin Saburi; Hossein Khedmat
Journal:  J Tehran Heart Cent       Date:  2014-01-12

10.  Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.

Authors:  Samshol Sukahri; Fatimah Zaherah Mohamed Shah; Ahmad Izuanuddin Ismail; Marymol Koshy; Bushra Johari; Mazuin Mohd Razali; Thuhairah Hasrah Abdul Rahman; Mohamad Rodi Isa; Rohana Abdul Ghani
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.